Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

First patient dosed in pivotal phase II FIREFLY-1 study of DAY-101 in pediatric low-grade glioma

May 12, 2021

Hamlet Pharma reports dose-escalation data on Alpha-1H in bladder cancer

May 11, 2021

Novel progression risk tissue markers in premalignant cervical lesions

May 11, 2021

First patient dosed in phase I/II study of CBX-12 in advanced or metastatic refractory solid tumors

May 11, 2021

G1 Therapeutics initiates phase II PRESERVE 4 study of trilaciclib in NSCLC

May 11, 2021

TroBio Therapeutics identifies new tropomyosin alpha-3 chain inhibitors

May 11, 2021

Stanford University presents new anticancer peptides

May 11, 2021

Enobosarm confers clinical benefit in patients with AR+/ER+ metastatic breast cancer

May 11, 2021

Findings bolster RAD51 as biomarker for DNA repair deficiency

May 10, 2021

VIP-236 demonstrates potent antitumor efficacy in xenograft models

May 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...